Meta-analytic evidence confirms elevation in peripheral levels of IL-6 and acute-phase proteins, like C-reactive protein (CRP), in patients with depression compared to controls (Goldsmith et al., 2016; Köhler et al., 2017; Osimo et al., 2020). Here, IL6 is linked to depressive symptom measurement.